전남대학교 중앙도서관

  • 중앙도서관
  • 여수캠퍼스도서관
  • 법학도서관
  • 치의학도서관
  • 의학도서관

링크메뉴

  • 화면키우기 화면줄이기 화면크기 원래대로
  • S
  • HOME
  • 로그인
  • 전남대
  • ENG
  • CHN

주메뉴

전체메뉴

전자자료 상세검색

전자자료 상세검색

통합검색
상세검색
검색어 [키워드: "Leneghan DB"]
총 8건 
※ 중복 레코드가 제거된 검색 결과가 표시됩니다.
1/1 페이지 RSS 엑셀파일 출력
검색결과수정
  • 검색범위확장
    • Full Text내 키워드 확장
    • 관련 주제어 확장

    재검색

  • 검색결과제한
    • 원문(Full Text)
    • Peer-Reviewed 학술지
    • 발행년 -

    재검색

  • 자료유형
    • Academic Journals (8)

    재검색

  • 주제
    • antibodies, protozoan (3)
    • malaria vaccines (3)
    • protozoan proteins (3)

    더보기

    재검색

  • 간행물
    • scientific reports (4)
    • cell reports (1)
    • frontiers in immunology (1)

    더보기

    재검색

  • 출판사
    • nature publishing group (4)
    • cell press (2)
    • cambridge university press (1)

    더보기

    재검색

  • 언어
    • english (8)

    재검색

  • 수록데이터베이스
    • MEDLINE (8)

    재검색

  • PQDTSearch
  • CAJSearch
  • RISSSearch
  • PsycINFOSearch

 

1
Instability of the HLA-E peptidome of HIV presents a major barrier to therapeutic targeting. 미리보기

학술저널

issue
Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2024 Mar 06; Vol. 32 (3), pp. 678-688. Date of Electronic Publication: 2024 Jan 12.
Author
Wallace Z; Immunocore Ltd., Abingdon, Oxfordshire OX14 4RY, UK. Electronic address: zoe.wallace@immunocore.com.
Heunis T; Immunocore Ltd., Abingdon, Oxfordshire OX14 4RY, UK.
Paterson RL; Immunocore Ltd., Abingdon, Oxfordshire OX14 4RY, UK.
Suckling RJ; Immunocore Ltd., Abingdon, Oxfordshire OX14 4RY, UK.
Grant T; Immunocore Ltd., Abingdon, Oxfordshire OX14 4RY, UK.
Dembek M; Immunocore Ltd., Abingdon, Oxfordshire OX14 4RY, UK.
Donoso J; Immunocore Ltd., Abingdon, Oxfordshire OX14 4RY, UK.
Brener J; Immunocore Ltd., Abingdon, Oxfordshire OX14 4RY, UK.
Long J; Immunocore Ltd., Abingdon, Oxfordshire OX14 4RY, UK.
Bunjobpol W; Immunocore Ltd., Abingdon, Oxfordshire OX14 4RY, UK.
Gibbs-Howe D; Immunocore Ltd., Abingdon, Oxfordshire OX14 4RY, UK.
Kay DP; Immunocore Ltd., Abingdon, Oxfordshire OX14 4RY, UK.
Leneghan DB; Immunocore Ltd., Abingdon, Oxfordshire OX14 4RY, UK.
Godinho LF; Immunocore Ltd., Abingdon, Oxfordshire OX14 4RY, UK.
Walker A; Immunocore Ltd., Abingdon, Oxfordshire OX14 4RY, UK.
Singh PK; Immunocore Ltd., Abingdon, Oxfordshire OX14 4RY, UK.
Knox A; Immunocore Ltd., Abingdon, Oxfordshire OX14 4RY, UK.
Leonard S; Immunocore Ltd., Abingdon, Oxfordshire OX14 4RY, UK.
Dorrell L; Immunocore Ltd., Abingdon, Oxfordshire OX14 4RY, UK.
DB Label
Database : MEDLINE
원문보기
등재 - Web of Science (SCIE)  등재 - SCOPUS  조회 - Impact Factor (JCR) 
2
Incoming HIV virion-derived Gag Spacer Peptide 2 (p1) is a target of effective CD8 + T cell antiviral responses. 미리보기

학술저널

issue
Cell reports [Cell Rep] 2021 May 11; Vol. 35 (6), pp. 109103.
Author
Yang H; Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK; National Institute for Health Research Oxford Biomedical Research Centre, University of Oxford, Oxford OX4 2PG, UK; Research In Viral Eradication of Reservoirs (RIVER) trial study group. Electronic address: hongbing.yang@ndm.ox.ac.uk.
Llano A; Irsicaixa AIDS Research Institute-HIVACAT, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Spain.
Cedeño S; Irsicaixa AIDS Research Institute-HIVACAT, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Spain.
von Delft A; National Institute for Health Research Oxford Biomedical Research Centre, University of Oxford, Oxford OX4 2PG, UK; Centre for Medicines Discovery, University of Oxford, Oxford, UK.
Corcuera A; Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK.
Gillespie GM; Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK.
Knox A; Immunocore Ltd, Milton, Abingdon OX14 4RY, UK.
Leneghan DB; Immunocore Ltd, Milton, Abingdon OX14 4RY, UK.
Frater J; Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK; National Institute for Health Research Oxford Biomedical Research Centre, University of Oxford, Oxford OX4 2PG, UK; Research In Viral Eradication of Reservoirs (RIVER) trial study group.
Stöhr W; Medical Research Council Clinical Trials Unit, University College London, London WC1V 6LJ, UK; Research In Viral Eradication of Reservoirs (RIVER) trial study group.
Fidler S; Department of Infectious Disease, Imperial College London, National Institute for Health Research Imperial Biomedical Research Centre, London W2 1NY, UK; Research In Viral Eradication of Reservoirs (RIVER) trial study group.
Mothe B; Irsicaixa AIDS Research Institute-HIVACAT, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Spain; Faculty of Medicine, Universitat de Vic-Central de Catalunya (UVic-UCC), 08500 Vic, Spain; Fundació Lluita contra la Sida, Infectious Disease Department, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Spain.
Mak J; Institute for Glycomics, Griffith University Gold Coast, Southport QLD 4215, Australia.
Brander C; Irsicaixa AIDS Research Institute-HIVACAT, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Spain; Faculty of Medicine, Universitat de Vic-Central de Catalunya (UVic-UCC), 08500 Vic, Spain; Institució Catalana de Recerca I Estudis Avançats (ICREA), 08010 Barcelona, Spain.
Ternette N; Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK.
Dorrell L; Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK; National Institute for Health Research Oxford Biomedical Research Centre, University of Oxford, Oxford OX4 2PG, UK; Immunocore Ltd, Milton, Abingdon OX14 4RY, UK; Research In Viral Eradication of Reservoirs (RIVER) trial study group. Electronic address: lucy.dorrell@ndm.ox.ac.uk.
DB Label
Database : MEDLINE
원문보기
Full Text (ScienceDirect O/A)  등재 - Web of Science (SCIE)  등재 - SCOPUS  조회 - Impact Factor (JCR) 
3
A Universal Plug-and-Display Vaccine Carrier Based on HBsAg VLP to Maximize Effective Antibody Response. 미리보기

학술저널

issue
Frontiers in immunology [Front Immunol] 2019 Dec 12; Vol. 10, pp. 2931. Date of Electronic Publication: 2019 Dec 12 (Print Publication: 2019).
Author
Marini A; Nuffield Department of Medicine, The Jenner Institute, University of Oxford, Oxford, United Kingdom.
Zhou Y; Nuffield Department of Medicine, The Jenner Institute, University of Oxford, Oxford, United Kingdom.
Li Y; Nuffield Department of Medicine, The Jenner Institute, University of Oxford, Oxford, United Kingdom.
Taylor IJ; Nuffield Department of Medicine, The Jenner Institute, University of Oxford, Oxford, United Kingdom.
Leneghan DB; Nuffield Department of Medicine, The Jenner Institute, University of Oxford, Oxford, United Kingdom.
Jin J; Nuffield Department of Medicine, The Jenner Institute, University of Oxford, Oxford, United Kingdom.
Zaric M; Nuffield Department of Medicine, The Jenner Institute, University of Oxford, Oxford, United Kingdom.
Mekhaiel D; Nuffield Department of Medicine, The Jenner Institute, University of Oxford, Oxford, United Kingdom.
Long CA; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Disease, National Institutes of Health, Rockville, MD, United States.
Miura K; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Disease, National Institutes of Health, Rockville, MD, United States.
Biswas S; Nuffield Department of Medicine, The Jenner Institute, University of Oxford, Oxford, United Kingdom.
DB Label
Database : MEDLINE
원문보기
Open Access (PubMed Central)  등재 - Web of Science (SCIE)  등재 - SCOPUS  조회 - Impact Factor (JCR) 
4
Nanoassembly routes stimulate conflicting antibody quantity and quality for transmission-blocking malaria vaccines. 미리보기

학술저널

issue
Scientific reports [Sci Rep] 2017 Jun 19; Vol. 7 (1), pp. 3811. Date of Electronic Publication: 2017 Jun 19.
Author
Leneghan DB; Jenner Institute, University of Oxford, Oxford, OX3 7DQ, UK. darren.leneghan@ndm.ox.ac.uk.
Miura K; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases/National Institutes of Health, Rockville, Maryland, 20852, USA.
Taylor IJ; Jenner Institute, University of Oxford, Oxford, OX3 7DQ, UK.
Li Y; Jenner Institute, University of Oxford, Oxford, OX3 7DQ, UK.
Jin J; Jenner Institute, University of Oxford, Oxford, OX3 7DQ, UK.
Brune KD; Department of Biochemistry, University of Oxford, South Parks Road, Oxford, OX1 3QU, UK.
Bachmann MF; Jenner Institute, University of Oxford, Oxford, OX3 7DQ, UK.; Inselspital, University of Bern, Bern, Switzerland.
Howarth M; Department of Biochemistry, University of Oxford, South Parks Road, Oxford, OX1 3QU, UK.
Long CA; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases/National Institutes of Health, Rockville, Maryland, 20852, USA.
Biswas S; Jenner Institute, University of Oxford, Oxford, OX3 7DQ, UK. sumi.biswas@ndm.ox.ac.uk.
DB Label
Database : MEDLINE
원문보기
OA (Springer)  OA (Nature)  Open Access (PubMed Central)  등재 - Web of Science (SCIE)  등재 - SCOPUS  조회 - Impact Factor (JCR) 
8
Enhancing immunogenicity and transmission-blocking activity of malaria vaccines by fusing Pfs25 to IMX313 multimerization technology. 미리보기

학술저널

issue
Scientific reports [Sci Rep] 2016 Jan 08; Vol. 6, pp. 18848. Date of Electronic Publication: 2016 Jan 08.
Author
Li Y; Jenner Institute, University of Oxford, Oxford, OX3 7DQ, UK.
Leneghan DB; Jenner Institute, University of Oxford, Oxford, OX3 7DQ, UK.
Miura K; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious. Disease/National Institutes of Health, Rockville, Maryland, USA.
Nikolaeva D; Jenner Institute, University of Oxford, Oxford, OX3 7DQ, UK.; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious. Disease/National Institutes of Health, Rockville, Maryland, USA.
Brian IJ; Jenner Institute, University of Oxford, Oxford, OX3 7DQ, UK.
Dicks MD; Jenner Institute, University of Oxford, Oxford, OX3 7DQ, UK.
Fyfe AJ; Jenner Institute, University of Oxford, Oxford, OX3 7DQ, UK.
Zakutansky SE; Jenner Institute, University of Oxford, Oxford, OX3 7DQ, UK.
de Cassan S; Jenner Institute, University of Oxford, Oxford, OX3 7DQ, UK.
Long CA; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious. Disease/National Institutes of Health, Rockville, Maryland, USA.
Draper SJ; Jenner Institute, University of Oxford, Oxford, OX3 7DQ, UK.
Hill AV; Jenner Institute, University of Oxford, Oxford, OX3 7DQ, UK.
Hill F; IMAXIO, 69007 Lyon, France.
Biswas S; Jenner Institute, University of Oxford, Oxford, OX3 7DQ, UK.
DB Label
Database : MEDLINE
원문보기
Full Text Full Text (원문보기) OA (Springer)  OA (Nature)  Open Access (PubMed Central)  등재 - Web of Science (SCIE)  등재 - SCOPUS  조회 - Impact Factor (JCR) 
1 
바구니보기

QUICK LINK

  • 희망도서신청
  • 대출/연장조회
  • 서가부재도서
  • 이용교육

마이메뉴추가

QRCode
  • 개인정보호정책
  • 이메일무단수집거부
  • 도서관이용문의

    • 도서관자치위원회  원격제어  Instagram  facebook  w  kakao 플친
500-757 광주광역시 북구 용봉로 77 TEL 062)530-3571~2(대출반납실) FAX 062)530-3529
Copyright@2013 CHONNAM NATIONAL UNIVERSITY LIBRARY, All Rights Reserved.
  • 37012
  • 126154615